Halyard Health, Inc. (HYH) Given Consensus Rating of “Buy” by Brokerages
Shares of Halyard Health, Inc. (NYSE:HYH) have received a consensus recommendation of “Buy” from the seven analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $42.25.
Several equities research analysts recently commented on the stock. BidaskClub raised shares of Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday, August 19th. Deutsche Bank AG lifted their target price on shares of Halyard Health from $35.00 to $42.00 and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Stephens raised shares of Halyard Health from an “equal weight” rating to an “overweight” rating in a research note on Thursday, August 3rd. TheStreet raised shares of Halyard Health from a “c” rating to a “b” rating in a research note on Thursday, June 22nd. Finally, Zacks Investment Research raised shares of Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 target price on the stock in a research note on Wednesday, July 12th.
Halyard Health (NYSE:HYH) traded up 0.13% during trading on Wednesday, reaching $45.37. 239,961 shares of the company’s stock traded hands. The company has a 50-day moving average price of $42.10 and a 200 day moving average price of $39.31. The firm has a market capitalization of $2.12 billion, a PE ratio of 43.62 and a beta of 1.76. Halyard Health has a one year low of $31.59 and a one year high of $45.61.
Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 EPS for the quarter, topping the consensus estimate of $0.37 by $0.14. The company had revenue of $399.20 million during the quarter, compared to analyst estimates of $399.16 million. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The firm’s revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.45 EPS. On average, analysts anticipate that Halyard Health will post $1.98 earnings per share for the current fiscal year.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Koch Industries Inc. acquired a new stake in Halyard Health during the 2nd quarter worth $297,000. Sterling Capital Management LLC acquired a new stake in Halyard Health during the 2nd quarter worth $631,000. Raymond James Financial Services Advisors Inc. acquired a new stake in Halyard Health during the 2nd quarter worth $217,000. The Manufacturers Life Insurance Company boosted its stake in Halyard Health by 0.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 102,917 shares of the medical instruments supplier’s stock worth $4,042,000 after purchasing an additional 575 shares during the last quarter. Finally, State Street Corp boosted its stake in Halyard Health by 7.5% during the 2nd quarter. State Street Corp now owns 1,702,423 shares of the medical instruments supplier’s stock worth $66,872,000 after purchasing an additional 119,154 shares during the last quarter. 91.02% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.thecerbatgem.com/2017/09/06/halyard-health-inc-hyh-given-consensus-rating-of-buy-by-brokerages.html.
Halyard Health Company Profile
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Stock Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related stocks with our FREE daily email newsletter.